Data / Form D filings / Pictor Labs, Inc.
Pictor Labs, Inc.: Form D filings
Pictor Labs, Inc., a biotechnology company in Los Angeles, CA, filed 5 Form D notices with the SEC between 2020 and 2024. The latest, on August 21, 2024, reports $20.6 million sold of a $30 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11390 W Olympic Blvd., Suite 250, Los Angeles, CA, 90064
- Phone
- (310) 500-6568
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1796802
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2024 | New notice | $29,999,993 | $20,586,916 | $9,413,077 | 8 | Aug 6, 2024 | sec.gov |
| May 27, 2022 | Amendment | $3,625,691 | $3,625,691 | 9 | Sep 21, 2020 | sec.gov | |
| May 27, 2022 | New notice | $15,215,000 | $7,607,500 | $7,607,500 | 5 | May 23, 2022 | sec.gov |
| Oct 7, 2020 | New notice | $3,908,024 | $616,873 | $3,291,151 | 2 | Sep 21, 2020 | sec.gov |
| Aug 10, 2020 | New notice | $9 | $9 | 2 | Sep 4, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bauke Anninga | Director | |
| Aydogan Ozcan | Director, Promoter | |
| Robert Crutchfield | Director | |
| Yair Rivenson | Executive Officer, Director, Promoter | |
| Scott Barclay | Director | |
| Gilbert Hakim | Director | |
| Polat Sen | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 19, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pictor Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.